Kestra Private Wealth Services’s West Pharmaceutical WST Stock Holding History

Kestra Private Wealth Services’s Portfolio WST Stock Details WST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$204K	Buy	+569	New	+$174K	﹤0.01%	1693
2022 Q4	–	Sell	-1,473	Closed	-$363K	–	998
2022 Q3	$363K	Sell	1,473 -819	-36%	-$249K	0.02%	587
2022 Q2	$693K	Sell	2,292 -225	-9%	-$73.2K	0.04%	415
2022 Q1	$1.03M	Sell	2,517 -853	-25%	-$334K	0.05%	371
2021 Q4	$1.58M	Buy	3,370 +2,436	+261%	+$1.05M	0.08%	282
2021 Q3	$397K	Buy	+934	New	+$394K	0.02%	605

Other funds holding WST

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

GIM

Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Kestra Private Wealth Services's WST Position: Q2 2026 in Review

Kestra Private Wealth Services opened a new position in West Pharmaceutical (WST) in Q2 2026: 569 shares worth $204K. The stake represents ﹤0.01% of the portfolio and ranks #1693 among its holdings. This is a return to the name: Kestra Private Wealth Services previously reported a position in WST as recently as Q3 2022.

Kestra Private Wealth Services first reported a position in WST in Q3 2021 and has held it in 6 quarters since. The position peaked at $1.58M in Q4 2021. 834 funds tracked by Wall St. Rank hold WST as of Q2 2026.

Kestra Private Wealth Services held 569 shares of West Pharmaceutical worth $204K as of Q2 2026.
West Pharmaceutical was a new Kestra Private Wealth Services position in Q2 2026.
West Pharmaceutical made up ﹤0.01% of Kestra Private Wealth Services's portfolio in Q2 2026, its #1693 holding.
Kestra Private Wealth Services first reported a position in West Pharmaceutical in Q3 2021 and has held it in 6 quarters since.
Kestra Private Wealth Services's West Pharmaceutical position peaked at $1.58M in Q4 2021.
834 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on Kestra Private Wealth Services's 13F filing for Q2 2026, filed 28 Jul 2026.